NEW YORK (GenomeWeb News) — CombiMatrix today said it stands to pocket $10 million when its parent company Acacia Research received commitments from “a select group of investors” to buy 9.8 million units of equity for $1.02 apiece
 
Each unit includes one Acacia Research-CombiMatrix share and a five-year warrant to buy 1.2 million shares at $.87 apiece. In afternoon trading today the stock was priced at $.88. The placement was handled by Oppenheimer & Co.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.